Tübingen (ots) - Acousia Therapeutics GmbH, a clinical-stage biotechnology company pioneering treatments for acute and chronic inner ear hearing loss, today announced positive top-line efficacy results from its completed Phase 2a PROHEAR Study. ACOU085 is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across ...
Europäischer Rechnungshof - European Court of Auditors
Europäischer Rechnungshof - European Court of Auditors
EUconomy - Partnerships4Prosperity
Europäischer Rechnungshof - European Court of Auditors
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small ...
Europäischer Rechnungshof - European Court of Auditors
Regione Sicilia - Assessorato turismo, sport e spettacolo
Palermo (ots) - Visiting a 'borgo' entails activating a form of immersion with all five of the senses highly aroused: in a village perched on the Madonie Mountains or stretched out comfortably above the sea, one looks, tastes, touches, smells and, above all, one listens: voices from the earth and from water, ...
Tübingen, Germany (ots) - Acousia Therapeutics GmbH announced that it has successfully enrolled 50% of patients in its ongoing Phase 2 clinical trial, the PROHEAR Study, evaluating ACOU085 (INN: bimokalner) for the prevention of cisplatin-induced hearing loss in patients with testicular cancer undergoing chemotherapy. Cisplatin is a cornerstone in modern oncology and ...
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, will be presenting the ACOU085 Phase 2 PROHEAR clinical study at the HansonWade 4th Inner Ear Disorders Therapeutics Summit in Boston (MA) from August ...
issuer: AMAG Austria Metall AG Lamprechtshausenerstraße 61 A-5282 Ranshofen phone: +43 7722 801 0 FAX: +43 7722 809 498 mail: investorrelations@amag.at WWW: www.amag-al4u.com ISIN: AT00000AMAG3 indexes: ATX GP, VÖNIX, ATX BI, WBI stockmarkets: Wien language: ...
Berlin, Germany (ots) - Coming soon, a coworking offer from rent24 will be available at 14 of the LGH Holiday Inn Hotels. The global operating coworking and coliving provider is expanding its location network in the UK to enable business travelers to work comfortably while traveling. "We are thrilled that we are able to collaborate with LGH which enables us to offer our fantastic concept and to create a win-win situation ...
Munich, Germany (ots) - Dr Andreas Seidl, hired as new Chief Operating Officer and member of the Executive Board, will be responsible for managing R&D operations as well as quality and regulatory, logistics and intellectual property of LEUKOCARE AG. He will assume his new role on April 1, 2019. Munich-based ...
Frankfurt (ots) - The Supervisory Board of Steigenberger Hotels AG has appointed Puneet Chhatwal as new Chief Executive Officer (CEO) of the Management Board. From January 1, 2013 onwards and together with Chief Financial Officer (CFO) Matthias Heck, Chhatwal will hold responsibility for the hotel business based in Frankfurt/Main. Steigenberger Hotels AG is very pleased to announce Puneet Chhatwal (48), who has deep and ...
Merlin Entertainments Group Deutschland
London, New York and Dubai (ots) - Merlin Entertainments Group ("Merlin"), controlled by the Blackstone Group ("Blackstone"), and The Tussauds Group ("TTG"), controlled by Dubai International Capital LLC ("DIC"), are today announcing a partnership of two rapidly growing businesses. This brings together ...
